Abstract
Aims
In this retrospective study, we aimed to evaluate the results of glaucoma surgery in patients with nanophthalmos.
Methods
Twenty-eight bilateral nanophthalmic patients, of whom 20 patients underwent trabeculectomy+Mitomycin-C (MMC)+inferior sclerotomy between 1996 and 2004, were included in this study. Records of patients with nanophthalmos were reviewed. Intraocular pressure (IOP), glaucoma medications, surgical success, visual acuity and complications were analyzed.
Results
The mean IOP was 34.6±5.3 mm Hg preoperatively. At the final follow-up visit, the mean IOP dropped to 21.41±7.34 mm Hg (P<0.05). The cumulative probability of success was 85% at 1 year, 78.5% at 2 years, 76.9% at 3 years, 70.6% at 4 years and 47% at 5 years after surgery. Visual acuity decreased in 13 (65%) patients but no eye lost vision. Sequels of choroidal detachment (five patients 25%) and retinal folds (four patients 20%) were the most frequent reason for visual decrease. Uveal effusion (10 patients 50%) and cataract formation (seven patients 35%) were major late postoperative complications.
Conclusions
Results indicate that trabeculectomy+MMC+inferior sclerotomy procedure was effective and safe for glaucoma control in patients with nanophthalmos, but uveal effusion is a major problem and cataract surgery is expected in the long run.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Duke-Elder S . Anomalies in the size of the eye. In Duke Elder S, (ed). System of Ophthalmology, Vol 3 pt 2. CV Mosby: St Louis, MA, 1964, pp 488.
Kimbrough RL, Trempe CS, Brockhurst RJ, Simmons RJ . Angle-closure glaucoma in nanophthalmos. Am J Ophthalmol 1979; 88: 572–579.
Singh OS, Simmons RJ, Brockhurst RJ, Temple CL . Nanophthalmos: a perspective on identification and therapy. Ophthalmology 1982; 89: 1006–1012.
Jin JC, Anderson DR . Laser and unsutured sclerotomy in nanophthalmos. Am J Ophthalmol 1990; 109: 575–580.
Auffarth GU, Blum M, Faller U, Tetz MR, Volcker HE . Relative anterior microphthalmos: morphometric analysis and its implications for cataract surgery. Ophthalmology 2000; 107: 1555–1560.
Burgoyne C, Tello C, Katz LJ . Nanophthalmia and chronic angle closure glaucoma. J Glaucoma 2002; 11: 525–528.
Ritch R, Chang BM, Liebmann JM . Angle closure in younger patients. Ophthalmology 2003; 110: 1880–1889.
Altintas AK, Acar MA, Yalvac IS, Kocak I, Nurozler A, Duman S . Autosomal recessive nanophthalmos. Acta Ophthalmol Scand 1997; 75: 325–328.
Kocak I, Altintas AK, Yalvac IS, Nurozler A, Kasim R, Duman S . Treatment of glaucoma in young nanophthalmic patients. Int Ophthalmol 1997; 20: 107–111.
Brockhurst RJ . Nanophthalmos with uveal effusion: a new clinical entity. Arch Ophthalmol 1975; 93: 1289–1299.
Yamani A, Wood I, Sugino I, Wanner M, Zarbin MA . Abnormal collagen fibrils in nanophthalmos: a Clinical and histologic study. Am J Ophthalmol 1999; 127: 106–108.
Shiono T, Shoji A, Mutoh T, Tamai M . Abnormal sclerocytes in nanophthalmos. Graefe's Arch Exp Ophthalmol 1992; 230: 348–351.
Stewart III D, Streeten BW, Brockhurst RJ, Anderson DR, Hirose T, Gass DM . Abnormal scleral collagen in nanophthalmos. An ultrastructural study. Arch Ophthalmol 1991; 109: 1017–1025.
Yue BY, Kurosawa A, Duvall J, Goldsberg MF, Tso MO, Sugar J . Nanophthalmic sclera. Morphologic and tissue culture studies. Ophthalmology 1986; 93: 534–541.
Brockhurst RJ . Vortex vein decompression for nanophthalmic uveal effusion. Arch Ophthalmol 1980; 98: 1987–1990.
Johnson MW, Gass DM . Surgical management of the idiopathic uveal effusion syndrome. Ophthalmology 1990; 97: 778–785.
Calhoun Jr FP . The management of glaucoma in nanophthalmos. Trans Am Ophthalmol Soc 1975; 73: 97–122.
Uyama M, Takahashi K, Kozaki J, Tagami N, Takada Y, Ohkuma H . Uveal effusion syndrome: clinical features, surgical treatment, histological examination of the sclera, and pathophysiology. Ophthalmology 2000; 107: 441–449.
Krohn J, Seland JH . Exudative retinal detachment in nanophthalmos. Acta Ophthalmol Scand 1998; 76: 499–502.
Sener EC, Mocan MC, Sarac OI, Gedik S, Sanac AS . Management of strabismus in nanophthalmic patients. A long-term follow-up. Ophthalmology 2003; 110: 1230–1236.
Serrano JC, Hodkings PR, Taylor DSI, Gole GA, Kriss A .The nanophthalmic macula. Br J Ophthalmol 1998; 82: 276–279.
Kharillah M, Messaoud R, Zaouali S, Ben Yahia S, Ladjimi A, Jenzri S . Posterior segment changes associated with posterior microphthalmos. Ophthalmology 2002; 109: 569–574.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no proprietary interest in any of the materials or techniques used in this study. Presented in part as a free paper presentation at the Annual Meeting of the American Academy of Ophthalmology, Chicago, IL; October 2005.
Rights and permissions
About this article
Cite this article
Yalvac, I., Satana, B., Ozkan, G. et al. Management of glaucoma in patients with nanophthalmos. Eye 22, 838–843 (2008). https://doi.org/10.1038/sj.eye.6702742
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6702742
Keywords
This article is cited by
-
Outcomes of combined phacoemulsification, anterior vitrectomy, and sclerectomy in nanophthalmic eyes with glaucoma
Eye (2023)
-
Prevalence of complications in eyes with nanophthalmos or microphthalmos: protocol for a systematic review and meta-analysis
Systematic Reviews (2022)
-
Phacoemulsification with double-in-bag intraocular lens implantation in nanophthalmic eyes with angle-closure glaucoma
International Ophthalmology (2022)
-
Clinical spectrum and treatment outcomes of patients with nanophthalmos
Eye (2021)
-
Glaukom und Nanophthalmus
Der Ophthalmologe (2019)
